C12N 2770/22011
Dicistroviridae
C12N2770/22011 (Dicistroviridae) appears on 11 US grants and 20 published applications in this corpus.
Search patents in C12N- Granted patents
- 11
- Published applications
- 20
- Assignees
- 11
- Inventors
- 45
- Latest grant
- 12 Jan 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 2 |
| 2004 | 0 | 3 |
| 2005 | 0 | 0 |
| 2006 | 1 | 3 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 3 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 1 | 2 |
| 2013 | 1 | 3 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 2 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
- C12N 2770/22022New viral proteins or individual genes, new structural or functional aspects ofIndexing code7
- C12N 2770/22034Use of virus or viral component as vaccineIndexing code3
- C12N 2770/22041Use of virus, viral particle or viral elements as a vectorIndexing code2
- C12N 2770/22023Virus like particles [vlp]Indexing code1
- C12N 2770/22021Viruses as suchIndexing code0
- C12N 2770/22031Uses of virus other than therapeutic or vaccineIndexing code0
- C12N 2770/22032Use of virus as therapeutic agent, other than vaccineIndexing code0
- C12N 2770/22033Use of viral protein as therapeutic agent other than vaccineIndexing code0
Recent patents
- Compositions for conferring tolerance to viral disease in social insects, and the use thereof12 Jan 2021US 10,888,579 B2Beeologics Inc.
- Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture9 Aug 2016US 9,408,902 B2
- Compositions for conferring tolerance to viral disease in social insects, and the use thereof13 Aug 2013US 8,507,457 B2Beeologics Inc.
- Compositions for conferring tolerance to viral disease in social insects, and the use thereof17 Jan 2012US 8,097,712 B2Beelogics Inc.
- Crustaceans as production systems for therapeutic proteins26 Apr 2011US 7,932,056 B2Advanced Bionutrition Corporation
- Nucleic acid molecules inserted expression regulation sequences, expression vector comprising nucleic acid moleclues and pharmaceutical use thereof4 Nov 2021US 2021/0340550 A1The Catholic University of Korea Industry-Academic Cooperation Foundation
- Compositions for conferring tolerance to viral disease in social insects, and the use thereof9 Sep 2021US 2021/0275566 A1Beeologics Inc.
- Compositions for conferring tolerance to viral disease in social insects, and the use thereof31 Oct 2013US 2013/0289097 A1Beeologics Inc.
- Methods and compositions for the treatment of cirrhosis and liver fibrosis17 Oct 2013US 2013/0273006 A1Proyecto De Biomedicina Cima, S.L.
- Expression Of Positive Sense Single Stranded RNA Virus And Uses Thereof1 Aug 2013US 2013/0195914 A1Viracine Therapeutics Corporation
Most cited
By later US patents
- Compositions for conferring tolerance to viral disease in social insects, and the use thereof17US 8,097,712 B2Beelogics Inc. · 2012
- Compositions for conferring tolerance to viral disease in social insects, and the use thereof11US 8,507,457 B2Beeologics Inc. · 2013
- Recombinant swinepox virus5US 5,869,312 ASyntro Corporation · 1999
- Avian polynucleotide formula5US 6,221,362 B1Merial Limited · 2001
- Compositions for conferring tolerance to viral disease in social insects, and the use thereof3US 10,888,579 B2Beeologics Inc. · 2021